Document is current

Any future updates will be listed below

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis

Crossref DOI link: https://doi.org/10.1186/s13045-015-0135-3

Published Online: 2015-04-23

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark